[go: up one dir, main page]

DE69509621D1 - Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung - Google Patents

Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung

Info

Publication number
DE69509621D1
DE69509621D1 DE69509621T DE69509621T DE69509621D1 DE 69509621 D1 DE69509621 D1 DE 69509621D1 DE 69509621 T DE69509621 T DE 69509621T DE 69509621 T DE69509621 T DE 69509621T DE 69509621 D1 DE69509621 D1 DE 69509621D1
Authority
DE
Germany
Prior art keywords
diarylheptanoid
derivative
same
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69509621T
Other languages
English (en)
Other versions
DE69509621T2 (de
Inventor
Ryuta Yamazaki
Takeshi C O K K Yaku Matsuzaki
Ritsuo Aiyama
Shusuke Hashimoto
Teruo Yokokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of DE69509621D1 publication Critical patent/DE69509621D1/de
Publication of DE69509621T2 publication Critical patent/DE69509621T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69509621T 1994-12-14 1995-12-13 Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung Expired - Fee Related DE69509621T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6310247A JPH08165267A (ja) 1994-12-14 1994-12-14 ジアリルヘプタノイド誘導体およびこれを含有する抗炎症剤

Publications (2)

Publication Number Publication Date
DE69509621D1 true DE69509621D1 (de) 1999-06-17
DE69509621T2 DE69509621T2 (de) 1999-09-02

Family

ID=18002953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69509621T Expired - Fee Related DE69509621T2 (de) 1994-12-14 1995-12-13 Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung

Country Status (6)

Country Link
US (1) US5763673A (de)
EP (1) EP0717027B1 (de)
JP (1) JPH08165267A (de)
CA (1) CA2164163A1 (de)
DE (1) DE69509621T2 (de)
ES (1) ES2132503T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261607B1 (en) 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
ES2425767T3 (es) 2007-09-21 2013-10-17 Pharmabrand S.A. Composición herbaria estimulante del sistema inmune, antitumoral y anti SIDA y proceso de elaboración de la misma
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP4276089A3 (de) * 2016-03-03 2023-12-20 Universite De Moncton Modulatoren der lypoxygenase- und cyclooxygenaseenzymaktivität
CN108469487B (zh) * 2018-05-29 2021-03-23 中国医科大学 草豆蔻中桤木酮的含量测定方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810716A (en) * 1986-04-11 1989-03-07 Warner-Lambert Company Diarylalkanoids having activity as lipoxygenase inhibitors

Also Published As

Publication number Publication date
ES2132503T3 (es) 1999-08-16
EP0717027B1 (de) 1999-05-12
DE69509621T2 (de) 1999-09-02
CA2164163A1 (en) 1996-06-15
EP0717027A1 (de) 1996-06-19
JPH08165267A (ja) 1996-06-25
US5763673A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR1100824A (pt) Composto e composição farmacêutica
DE69124721D1 (de) Carbostyrilderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69525148D1 (de) Pharmazeutische formulierung
DE69723398T2 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI953479A7 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
FI944832L (fi) Farmaseuttinen koostumus
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
DE69510920D1 (de) Galaktomannan-produkte und diese enthaltende zusammensetzungen
IL115563A0 (en) Benzoxazole derivatives and pharmaceutical compositions containing the same
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
BR9509688A (pt) Composto e composição farmacêutica
BR9507768A (pt) Composição farmacêutica
ITMI941169A0 (it) Formulazioni farmaceutiche
DE69223835D1 (de) Neue Aminophenolderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
DE69725166D1 (de) Substituierte benzamidderivate und diese enthaltende pharmazeutische zusammensetzung
DE69509621D1 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
BR9509055A (pt) Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee